Robust ICG theranostic nanoparticles for folate targeted cancer imaging and highly effective photothermal therapy

ACS Appl Mater Interfaces. 2014 May 14;6(9):6709-16. doi: 10.1021/am5004393. Epub 2014 Apr 15.

Abstract

Folic acid (FA)-targeted indocyanine green (ICG)-loaded nanoparticles (NPs) (FA-INPs) were developed to a near-infrared (NIR) fluorescence theranostic nanoprobe for targeted imaging and photothermal therapy of cancer. The FA-INPs with good monodispersity exhibited excellent size and fluorescence stability, preferable temperature response under laser irradiation, and specific molecular targeting to MCF-7 cells with FA receptor overexpression, compared to free ICG. The FA-INPs enabled NIR fluorescence imaging to in situ monitor the tumor accumulation of the ICG. The cell survival rate assays in vitro and photothermal therapy treatments in vivo indicated that FA-INPs could efficiently targeted and suppressed MCF-7 cells and xenograft tumors. Hence, the FA-INPs are notable theranostic NPs for imaging-guided cancer therapy in clinical application.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / therapy
  • Cell Line, Tumor
  • Female
  • Folic Acid / metabolism*
  • Humans
  • Hyperthermia, Induced*
  • Mice
  • Mice, Nude
  • Nanoparticles*
  • Phototherapy*
  • Spectrometry, Fluorescence

Substances

  • Folic Acid